{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:44:18Z","timestamp":1777891458769,"version":"3.51.4"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11302-025-10122-6","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T04:14:37Z","timestamp":1771215277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulation of immune responses by opioids through toll-like and P2X receptor signaling in COVID-19"],"prefix":"10.1007","volume":"22","author":[{"given":"Mohammad Abbas","family":"Sheikholeslami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siavash","family":"Parvardeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Ghafghazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"10122_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12272-020-01301-7","volume":"44","author":"C Lee","year":"2021","unstructured":"Lee C, Choi WJ (2021) Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective. Arch Pharm Res 44:99\u2013116","journal-title":"Arch Pharm Res"},{"key":"10122_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/14787210.2020.1797487","volume":"18","author":"K Habas","year":"2020","unstructured":"Habas K, Nganwuchu C, Shahzad F, Gopalan R, Haque M, Rahman S, Majumder AA, Nasim T (2020) Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti Infect Ther 18:1201\u20131211. https:\/\/doi.org\/10.1080\/14787210.2020.1797487","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10122_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011267","author":"PP Avdonin","year":"2024","unstructured":"Avdonin PP, Blinova MS, Serkova AA, Komleva LA, Avdonin PV (2024) Immunity and coagulation in COVID-19. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252011267","journal-title":"Int J Mol Sci"},{"key":"10122_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-020-00532-2","volume":"23","author":"J Majumder","year":"2021","unstructured":"Majumder J, Minko T (2021) Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J 23:1\u201322","journal-title":"AAPS J"},{"key":"10122_CR5","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00532-2","volume":"23","author":"J Majumder","year":"2021","unstructured":"Majumder J, Minko T (2021) Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS J 23:14. https:\/\/doi.org\/10.1208\/s12248-020-00532-2","journal-title":"AAPS J"},{"key":"10122_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M, Blish CA, Sallusto F, Iwasaki A (2022) The immunology and immunopathology of COVID-19. Science 375:1122\u20131127. https:\/\/doi.org\/10.1126\/science.abm8108","journal-title":"Science"},{"key":"10122_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/164_2022_586","volume":"276","author":"J Liu","year":"2022","unstructured":"Liu J, Li JX, Wu R (2022) Toll-like receptor 4: a novel target to tackle drug addiction? Handb Exp Pharmacol 276:275\u2013290. https:\/\/doi.org\/10.1007\/164_2022_586","journal-title":"Handb Exp Pharmacol"},{"key":"10122_CR8","doi-asserted-by":"crossref","unstructured":"Gonzalez-Espinosa C, Madera-Salcedo IK, Molina-Mart\u00ednez LM, Mart\u00ednez-Cuevas FL (2022) Opioids and the immune system. Opioids: pharmacology, abuse, and addiction. Springer International Publishing, Cham, pp 249\u2013285","DOI":"10.1007\/978-3-031-09936-6_12"},{"key":"10122_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/jmv.25910","volume":"92","author":"J Zhu","year":"2020","unstructured":"Zhu J, Zhong Z, Li H, Ji P, Pang J, Li B, Zhang J (2020) CT imaging features of 4121 patients with COVID-19: a meta-analysis. J Med Virol 92:891\u2013902","journal-title":"J Med Virol"},{"key":"10122_CR10","doi-asserted-by":"crossref","unstructured":"Peng QY, Wang XT, Zhang LN, Chinese Critical Care Ultrasound Study Group (2020) Findings of lung ultrasonography of novel corona virus pneumonia during the 2019\u20132020 epidemic. Intensive Care Med 46:849\u2013850.","DOI":"10.1007\/s00134-020-05996-6"},{"key":"10122_CR11","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA 323:1061\u20131069","journal-title":"JAMA"},{"key":"10122_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0194599820926473","volume":"163","author":"JY Tong","year":"2020","unstructured":"Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T (2020) The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 163:3\u201311","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10122_CR13","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1007\/s00405-020-06102-8","volume":"277","author":"S Meini","year":"2020","unstructured":"Meini S, Suardi LR, Busoni M, Roberts AT, Fortini A (2020) Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Otorhinolaryngol 277:3519\u20133523","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10122_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120\u2013128","journal-title":"N Engl J Med"},{"key":"10122_CR15","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180:934\u2013943","journal-title":"JAMA Intern Med"},{"key":"10122_CR16","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1002\/jmv.26149","volume":"92","author":"L Quartuccio","year":"2020","unstructured":"Quartuccio L, Sonaglia A, Pecori D, Peghin M, Fabris M, Tascini C, De Vita S (2020) Higher levels of IL\u20106 early after tocilizumab distinguish survivors from nonsurvivors in COVID\u201019 pneumonia: a possible indication for deeper targeting of IL\u20106. J Med Virol 92:2852\u20132856","journal-title":"J Med Virol"},{"key":"10122_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fimmu.2018.00312","volume":"9","author":"S Oehmcke-Hecht","year":"2018","unstructured":"Oehmcke-Hecht S, K\u00f6hler J (2018) Interaction of the human contact system with pathogens\u2014an update. Front Immunol 9:312","journal-title":"Front Immunol"},{"key":"10122_CR18","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1073\/pnas.0608647104","volume":"104","author":"C Kannemeier","year":"2007","unstructured":"Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P, Song Y, Tzima E, Kennerknecht E, Niepmann M (2007) Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 104:6388\u20136393","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10122_CR19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1160\/TH-16-11-0858","volume":"117","author":"KT Preissner","year":"2017","unstructured":"Preissner KT, Herwald H (2017) Extracellular nucleic acids in immunity and cardiovascular responses: between alert and disease. Thromb Haemost 117:1272\u20131282","journal-title":"Thromb Haemost"},{"key":"10122_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/jth.13194","volume":"14","author":"A Schmaier","year":"2016","unstructured":"Schmaier A (2016) The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities. J Thromb Haemost 14:28\u201339","journal-title":"J Thromb Haemost"},{"key":"10122_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-12-800100-4.00002-7","volume":"121","author":"AP Kaplan","year":"2014","unstructured":"Kaplan AP, Joseph K (2014) Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol 121:41\u201389","journal-title":"Adv Immunol"},{"key":"10122_CR22","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1111\/bph.15154","volume":"177","author":"C Colarusso","year":"2020","unstructured":"Colarusso C, Terlizzi M, Pinto A, Sorrentino R (2020) A lesson from a saboteur: high-MW kininogen impact in coronavirus-induced disease 2019. Br J Pharmacol 177:4866\u20134872. https:\/\/doi.org\/10.1111\/bph.15154","journal-title":"Br J Pharmacol"},{"key":"10122_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/10408363.2018.1529734","volume":"55","author":"J Favresse","year":"2018","unstructured":"Favresse J, Lippi G, Roy P-M, Chatelain B, Jacqmin H, Ten Cate H, Mullier F (2018) D-dimer: preanalytical, analytical, postanalytical variables, and clinical applications. Crit Rev Clin Lab Sci 55:548\u2013577","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10122_CR24","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3389\/fimmu.2019.02046","volume":"10","author":"C Maas","year":"2019","unstructured":"Maas C (2019) Plasminflammation\u2014an emerging pathway to bradykinin production. Front Immunol 10:2046","journal-title":"Front Immunol"},{"key":"10122_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1084\/jem.133.4.696","volume":"133","author":"AP Kaplan","year":"1971","unstructured":"Kaplan AP, Austen KF (1971) A prealbumin activator of prekallikrein: II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med 133:696\u2013712","journal-title":"J Exp Med"},{"key":"10122_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1538-7836.2010.03789.x","volume":"8","author":"E Gershom","year":"2010","unstructured":"Gershom E, Sutherland M, Lollar P, Pryzdial E (2010) Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation. J Thromb Haemost 8:1037\u20131043","journal-title":"J Thromb Haemost"},{"key":"10122_CR27","first-page":"5111","volume":"115","author":"GA LaRusch","year":"2010","unstructured":"LaRusch GA, Mahdi F, Shariat-Madar Z, Adams G, Sitrin RG, Zhang WM, McCrae KR, Schmaier AH (2010) Factor XII stimulates ERK1\/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis. Blood J Am Soc Hematol 115:5111\u20135120","journal-title":"Blood J Am Soc Hematol"},{"key":"10122_CR28","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1074\/jbc.M114.606343","volume":"290","author":"L Wujak","year":"2015","unstructured":"Wujak L, Didiasova M, Zakrzewicz D, Frey H, Schaefer L, Wygrecka M (2015) Heparan sulfate proteoglycans mediate factor XIIa binding to the cell surface. J Biol Chem 290:7027\u20137039","journal-title":"J Biol Chem"},{"key":"10122_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","volume":"149","author":"J Lei","year":"2018","unstructured":"Lei J, Kusov Y, Hilgenfeld R (2018) Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Res 149:58\u201374","journal-title":"Antiviral Res"},{"key":"10122_CR30","first-page":"129","volume":"120","author":"J Kleniewski","year":"1992","unstructured":"Kleniewski J, Blankenship DT, Cardin AD, Donaldson V (1992) Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. J Lab Clin Med 120:129\u2013139","journal-title":"J Lab Clin Med"},{"key":"10122_CR31","doi-asserted-by":"publisher","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","volume":"314","author":"CP Sodhi","year":"2018","unstructured":"Sodhi CP, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton WB, Wang S, McCray PB Jr, Chappell M, Hackam DJ, Jia H (2018) Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Physiol Lung Cell Mol Physiol 314:L17\u2013L31","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10122_CR32","doi-asserted-by":"publisher","first-page":"106305","DOI":"10.1016\/j.intimp.2020.106305","volume":"82","author":"F Marceau","year":"2020","unstructured":"Marceau F, Bachelard H, Bouthillier J, Fortin J-P, Morissette G, Bawolak M-T, Charest-Morin X, Gera L (2020) Bradykinin receptors: agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. Int Immunopharmacol 82:106305","journal-title":"Int Immunopharmacol"},{"key":"10122_CR33","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3892\/or.2014.3366","volume":"32","author":"G Wang","year":"2014","unstructured":"Wang G, Ye Y, Zhang X, Song J (2014) Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells. Oncol Rep 32:1709\u20131714","journal-title":"Oncol Rep"},{"key":"10122_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/rheumatology\/kei282","volume":"45","author":"C-H Jang","year":"2006","unstructured":"Jang C-H, Choi J-H, Byun M-S, Jue D-M (2006) Chloroquine inhibits production of TNF-\u03b1, IL-1\u03b2 and IL-6 from lipopolysaccharide-stimulated human monocytes\/macrophages by different modes. Rheumatology 45:703\u2013710","journal-title":"Rheumatology"},{"key":"10122_CR35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/hy0302.105767","volume":"39","author":"M Pretorius","year":"2002","unstructured":"Pretorius M, Rosenbaum DA, Lefebvre J, Vaughan DE, Brown NJ (2002) Smoking impairs bradykinin-stimulated t-PA release. Hypertension 39:767\u2013771","journal-title":"Hypertension"},{"key":"10122_CR36","doi-asserted-by":"publisher","first-page":"e1003470","DOI":"10.1371\/journal.ppat.1003470","volume":"9","author":"SL Taylor","year":"2013","unstructured":"Taylor SL, Wahl-Jensen V, Copeland AM, Jahrling PB, Schmaljohn CS (2013) Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog 9:e1003470","journal-title":"PLoS Pathog"},{"key":"10122_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1124\/jpet.110.171876","volume":"335","author":"KJ Broadley","year":"2010","unstructured":"Broadley KJ, Blair AE, Kidd EJ, Bugert JJ, Ford WR (2010) Bradykinin-induced lung inflammation and bronchoconstriction: role in parainfluenze-3 virus-induced inflammation and airway hyperreactivity. J Pharmacol Exp Ther 335:681\u2013692","journal-title":"J Pharmacol Exp Ther"},{"key":"10122_CR38","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2174\/138161207780618911","volume":"13","author":"E Lazartigues","year":"2007","unstructured":"Lazartigues E, Feng Y, Lavoie JL (2007) The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Curr Pharm Des 13:1231\u20131245","journal-title":"Curr Pharm Des"},{"key":"10122_CR39","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.2500\/ajra.2017.31.4403","volume":"31","author":"GA Scangas","year":"2017","unstructured":"Scangas GA, Bleier BS (2017) Anosmia: differential diagnosis, evaluation, and management. Am J Rhinol Allergy 31:e3\u2013e7","journal-title":"Am J Rhinol Allergy"},{"key":"10122_CR40","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner AJ, Raizada MK, Grant MB, Oudit GY (2020) Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 126:1456\u20131474","journal-title":"Circ Res"},{"key":"10122_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:112\u2013116","journal-title":"Nature"},{"key":"10122_CR42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4196\/kjpp.2018.22.4.447","volume":"22","author":"SA Cha","year":"2018","unstructured":"Cha SA, Park BM, Kim SH (2018) Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor. Off J Korean Physiol Soc Korean Soc Pharmacol 22:447","journal-title":"Off J Korean Physiol Soc Korean Soc Pharmacol"},{"key":"10122_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280. e8","journal-title":"Cell"},{"key":"10122_CR44","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.ijantimicag.2020.105938","volume":"55","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain J-M, Colson P, Raoult D (2020) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents 55:105938","journal-title":"Int J Antimicrob Agents"},{"key":"10122_CR45","doi-asserted-by":"crossref","unstructured":"Diaz, J. H. (2020) Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med 27:taaa041","DOI":"10.1093\/jtm\/taaa041"},{"key":"10122_CR46","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"AJ Danser","year":"2020","unstructured":"Danser AJ, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension 75:1382\u20131385","journal-title":"Hypertension"},{"key":"10122_CR47","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S (2020) Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of COVID-19. N Engl J Med 382:2441\u20132448","journal-title":"N Engl J Med"},{"key":"10122_CR48","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G (2020) Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of COVID-19. N Engl J Med 382:2431\u20132440","journal-title":"N Engl J Med"},{"key":"10122_CR49","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324:782\u2013793","journal-title":"JAMA"},{"key":"10122_CR50","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","volume":"383","author":"DA Berlin","year":"2020","unstructured":"Berlin DA, Gulick RM, Martinez FJ (2020) Severe COVID-19. N Engl J Med 383:2451\u20132460","journal-title":"N Engl J Med"},{"key":"10122_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2488-1","volume":"584","author":"E Lavezzo","year":"2020","unstructured":"Lavezzo E, Franchin E, Ciavarella C, Cuomo-Dannenburg G, Barzon L, Del Vecchio C, Rossi L, Manganelli R, Loregian A, Navarin N (2020) Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo\u2019. Nature 584:425\u2013429","journal-title":"Nature"},{"key":"10122_CR52","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH (2020) Cytokine storm. N Engl J Med 383:2255\u20132273","journal-title":"N Engl J Med"},{"key":"10122_CR53","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033\u20131034","journal-title":"Lancet"},{"key":"10122_CR54","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3389\/fimmu.2020.01625","volume":"11","author":"A Bonaventura","year":"2020","unstructured":"Bonaventura A, Vecchi\u00e9 A, Wang TS, Lee E, Cremer PC, Carey B, Rajendram P, Hudock KM, Korbee L, Van Tassell BW (2020) Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies. Front Immunol 11:1625","journal-title":"Front Immunol"},{"key":"10122_CR55","first-page":"e0178","volume":"2","author":"LF Buckley","year":"2020","unstructured":"Buckley LF, Wohlford GF, Ting C, Alahmed A, Van Tassell BW, Abbate A, Devlin JW, Libby P (2020) Role for anti-cytokine therapies in severe coronavirus disease 2019. Crit Care Explor 2:e0178","journal-title":"Crit Care Explor"},{"key":"10122_CR56","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506","journal-title":"Lancet"},{"key":"10122_CR57","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/jcp.30008","volume":"236","author":"A Vecchie","year":"2021","unstructured":"Vecchie A, Bonaventura A, Toldo S, Dagna L, Dinarello CA, Abbate A (2021) IL-18 and infections: is there a role for targeted therapies? J Cell Physiol 236:1638\u20131657","journal-title":"J Cell Physiol"},{"key":"10122_CR58","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, M\u00f8ller R, Jordan TX, Oishi K, Panis M, Sachs D (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181:1036-1045. e9","journal-title":"Cell"},{"key":"10122_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00011-020-01413-2","volume":"70","author":"S Toldo","year":"2021","unstructured":"Toldo S, Bussani R, Nuzzi V, Bonaventura A, Mauro AG, Cannat\u00e0 A, Pillappa R, Sinagra G, Nana-Sinkam P, Sime P (2021) Inflammasome formation in the lungs of patients with fatal COVID-19. Inflamm Res 70:7\u201310","journal-title":"Inflamm Res"},{"key":"10122_CR60","doi-asserted-by":"crossref","unstructured":"Rodrigues TS, de S\u00e1 KS, Ishimoto AY, Becerra A, Oliveira S, Almeida L, Gon\u00e7alves AV, Perucello DB, Andrade WA, Castro R (2021) Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med 218(3):e20201707","DOI":"10.1084\/jem.20201707"},{"key":"10122_CR61","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","volume":"58","author":"BM Henry","year":"2020","unstructured":"Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G (2020) Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med (CCLM) 58:1021\u20131028","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"10122_CR62","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","volume":"2","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, O\u2019Donnell JS, Sharif K, Emery P, Bridgewood C (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatology 2:e437\u2013e445","journal-title":"Lancet Rheumatology"},{"key":"10122_CR63","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, Cheng L, Li J, Wang X, Wang F (2020) Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med 26:842\u2013844","journal-title":"Nat Med"},{"key":"10122_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41577-020-00470-2","volume":"21","author":"R Alon","year":"2021","unstructured":"Alon R, Sportiello M, Kozlovski S, Kumar A, Reilly EC, Zarbock A, Garbi N, Topham DJ (2021) Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19. Nat Rev Immunol 21:49\u201364","journal-title":"Nat Rev Immunol"},{"key":"10122_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/ijms22010315","volume":"22","author":"J Brejchova","year":"2020","unstructured":"Brejchova J, Holan V, Svoboda P (2020) Expression of opioid receptors in cells of the immune system. Int J Mol Sci 22:315","journal-title":"Int J Mol Sci"},{"key":"10122_CR66","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0963689718811060","volume":"28","author":"S Wang","year":"2019","unstructured":"Wang S (2019) Historical review: opiate addiction and opioid receptors. Cell Transplant 28:233\u2013238. https:\/\/doi.org\/10.1177\/0963689718811060","journal-title":"Cell Transplant"},{"key":"10122_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010315","author":"J Brejchova","year":"2020","unstructured":"Brejchova J, Holan V, Svoboda P (2020) Expression of opioid receptors in cells of the immune system. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22010315","journal-title":"Int J Mol Sci"},{"key":"10122_CR68","first-page":"5","volume":"1","author":"X Liang","year":"2016","unstructured":"Liang X, Liu R, Chen C, Ji F, Li T (2016) Opioid system modulates the immune function: a review. Translational perioperative and pain medicine 1:5\u201313","journal-title":"Translational perioperative and pain medicine"},{"key":"10122_CR69","doi-asserted-by":"publisher","first-page":"814241","DOI":"10.3389\/fphar.2021.814241","volume":"12","author":"S Wen","year":"2021","unstructured":"Wen S, Jiang Y, Liang S, Cheng Z, Zhu X, Guo Q (2021) Opioids regulate the immune system: focusing on macrophages and their organelles. Front Pharmacol 12:814241. https:\/\/doi.org\/10.3389\/fphar.2021.814241","journal-title":"Front Pharmacol"},{"key":"10122_CR70","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","volume":"10","author":"TK Eisenstein","year":"2019","unstructured":"Eisenstein TK (2019) The role of opioid receptors in immune system function. Front Immunol 10:2904","journal-title":"Front Immunol"},{"key":"10122_CR71","doi-asserted-by":"publisher","first-page":"1265511","DOI":"10.3389\/fimmu.2023.1265511","volume":"14","author":"VR Bataduwaarachchi","year":"2023","unstructured":"Bataduwaarachchi VR, Hansanie S, Rockwood N, D\u2019Cruz LG (2023) Immunomodulatory properties of morphine and the hypothesised role of long-term opioid use in the immunopathogenesis of tuberculosis. Front Immunol 14:1265511. https:\/\/doi.org\/10.3389\/fimmu.2023.1265511","journal-title":"Front Immunol"},{"key":"10122_CR72","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1128\/CDLI.7.5.719-723.2000","volume":"7","author":"JM Bidlack","year":"2000","unstructured":"Bidlack JM (2000) Detection and function of opioid receptors on cells from the immune system. Clinical Diagnostic Laboratory Immunology 7:719\u2013723","journal-title":"Clinical Diagnostic Laboratory Immunology"},{"key":"10122_CR73","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/bph.13750","volume":"175","author":"LM Plein","year":"2018","unstructured":"Plein LM, Rittner HL (2018) Opioids and the immune system\u2013friend or foe. Br J Pharmacol 175:2717\u20132725","journal-title":"Br J Pharmacol"},{"key":"10122_CR74","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00005-012-0186-x","volume":"60","author":"E Wypasek","year":"2012","unstructured":"Wypasek E, Natorska J, Mazur AI, Ko\u0142aczkowska E (2012) Toll-like receptors expression and NF-\u03baB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice. Arch Immunol Ther Exp (Warsz) 60:373\u2013382","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10122_CR75","doi-asserted-by":"publisher","first-page":"e18190","DOI":"10.1371\/journal.pone.0018190","volume":"6","author":"L He","year":"2011","unstructured":"He L, Li H, Chen L, Miao J, Jiang Y, Zhang Y, Xiao Z, Hanley G, Li Y, Zhang X (2011) Toll-like receptor 9 is required for opioid-induced microglia apoptosis. PLoS ONE 6:e18190","journal-title":"PLoS ONE"},{"key":"10122_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-021-02072-8","volume":"18","author":"CD Gipson","year":"2021","unstructured":"Gipson CD, Rawls S, Scofield MD, Siemsen BM, Bondy EO, Maher EE (2021) Interactions of neuroimmune signaling and glutamate plasticity in addiction. J Neuroinflammation 18:1\u201323","journal-title":"J Neuroinflammation"},{"key":"10122_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/fcp.12719","volume":"36","author":"M Zarei","year":"2022","unstructured":"Zarei M, Sabetkasaei M, Moini Zanjani T, Sahebi Vaighan N (2022) The effect of microglial inhibition on the expression of BDNF, KCC2, and GABAA receptor before and after the establishment of CCI-induced neuropathic pain model. Fundam Clin Pharmacol 36:277\u2013285","journal-title":"Fundam Clin Pharmacol"},{"key":"10122_CR78","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0376-8716(00)00181-2","volume":"62","author":"L McCarthy","year":"2001","unstructured":"McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62:111\u2013123. https:\/\/doi.org\/10.1016\/s0376-8716(00)00181-2","journal-title":"Drug Alcohol Depend"},{"key":"10122_CR79","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0034-7094(12)70169-1","volume":"62","author":"JB Garcia","year":"2012","unstructured":"Garcia JB, Cardoso MG, Dos-Santos MC (2012) Opioids and the immune system: clinical relevance. Rev Bras Anestesiol 62:709\u2013718. https:\/\/doi.org\/10.1016\/s0034-7094(12)70169-1","journal-title":"Rev Bras Anestesiol"},{"key":"10122_CR80","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1111\/bph.13903","volume":"175","author":"JW Boland","year":"2018","unstructured":"Boland JW, Pockley AG (2018) Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol 175:2726\u20132736","journal-title":"Br J Pharmacol"},{"key":"10122_CR81","unstructured":"Tariq I, Farhan A, Ashfaq UA, Qasim M, Humayun F, Shah M, Munir A, Masoud MS (2019) Study on structural insight of the analysis of negative effects of opioids analgesics in naltrexone with TLR4 Mutations. Pak J Pharm Sci 32(1):345\u2013351"},{"key":"10122_CR82","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/CCM.0b013e31826767a8","volume":"41","author":"V Salimi","year":"2013","unstructured":"Salimi V, Hennus MP, Mokhtari-Azad T, Shokri F, Janssen R, Hodemaekers HM, Rygiel TP, Coenjaerts FE, Meyaard L, Bont L (2013) Opioid receptors control viral replication in the airways. Crit Care Med 41:205\u2013214","journal-title":"Crit Care Med"},{"key":"10122_CR83","first-page":"148","volume":"521","author":"JS Walker","year":"2003","unstructured":"Walker JS (2003) Anti-inflammatory effects of opioids. Adv Exp Med Biol 521:148\u2013155","journal-title":"Adv Exp Med Biol"},{"key":"10122_CR84","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1113\/EP087783","volume":"104","author":"S Ji","year":"2019","unstructured":"Ji S, Wang L (2019) \u03bc-opioid receptor signalling via PI3K\/Akt pathway ameliorates lipopolysaccharide-induced acute respiratory distress syndrome. Exp Physiol 104:1555\u20131561","journal-title":"Exp Physiol"},{"key":"10122_CR85","first-page":"4298","volume":"22","author":"Q Hu","year":"2020","unstructured":"Hu Q, Wang Q, Han C, Yang Y (2020) Sufentanil attenuates inflammation and oxidative stress in sepsis-induced acute lung injury by downregulating KNG1 expression. Mol Med Rep 22:4298\u20134306","journal-title":"Mol Med Rep"},{"key":"10122_CR86","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3389\/fimmu.2018.01523","volume":"9","author":"L Nie","year":"2018","unstructured":"Nie L, Cai S-Y, Shao J-Z, Chen J (2018) Toll-like receptors, associated biological roles, and signaling networks in non-mammals. Front Immunol 9:1523","journal-title":"Front Immunol"},{"key":"10122_CR87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000102054","volume":"92","author":"A Fleer","year":"2007","unstructured":"Fleer A, Krediet TG (2007) Innate immunity: toll-like receptors and some more: a brief history, basic organization and relevance for the human newborn. Neonatology 92:145\u2013157","journal-title":"Neonatology"},{"key":"10122_CR88","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester SN, Li K (2014) Toll-like receptors in antiviral innate immunity. J Mol Biol 426:1246\u20131264","journal-title":"J Mol Biol"},{"key":"10122_CR89","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s11010-024-05137-3","volume":"480","author":"BRC Dos Santos","year":"2025","unstructured":"Dos Santos BRC, Dos Santos LKC, Ferreira JM, Dos Santos ACM, Sortica VA, de Souza Figueiredo EVM (2025) Toll-like receptors polymorphisms and COVID-19: a systematic review. Mol Cell Biochem 480:2677\u20132688","journal-title":"Mol Cell Biochem"},{"key":"10122_CR90","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461","journal-title":"Front Immunol"},{"key":"10122_CR91","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637\u2013650","journal-title":"Immunity"},{"key":"10122_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-019-0227-2","volume":"43","author":"SR El-Zayat","year":"2019","unstructured":"El-Zayat SR, Sibaii H, Mannaa FA (2019) Toll-like receptors activation, signaling, and targeting: an overview. Bull Natl Res Cent 43:1\u201312","journal-title":"Bull Natl Res Cent"},{"key":"10122_CR93","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1074\/jbc.275.4.2251","volume":"275","author":"K Kawasaki","year":"2000","unstructured":"Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M (2000) Mouse toll-like receptor 4\u00b7 MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 275:2251\u20132254","journal-title":"J Biol Chem"},{"key":"10122_CR94","doi-asserted-by":"crossref","unstructured":"Kunal S, Gupta K, Sharma SM, Pathak V, Mittal S, Tarke C (2020) Cardiovascular system and COVID-19: perspectives from a developing country. Monaldi Archives for Chest Disease 90","DOI":"10.4081\/monaldi.2020.1305"},{"key":"10122_CR95","doi-asserted-by":"publisher","first-page":"107087","DOI":"10.1016\/j.intimp.2020.107087","volume":"89","author":"V Kumar","year":"2020","unstructured":"Kumar V (2020) Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol 89:107087","journal-title":"Int Immunopharmacol"},{"key":"10122_CR96","doi-asserted-by":"publisher","unstructured":"Totura AL, Whitmore A, Agnihothram S, Sch\u00e4fer A, Katze MG, Heise MT, Baric RS (2015) Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. MBio 6. https:\/\/doi.org\/10.1128\/mbio.00638-15","DOI":"10.1128\/mbio.00638-15"},{"key":"10122_CR97","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.immuni.2010.03.012","volume":"32","author":"AL Blasius","year":"2010","unstructured":"Blasius AL, Beutler B (2010) Intracellular toll-like receptors. Immunity 32:305\u2013315","journal-title":"Immunity"},{"key":"10122_CR98","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.20060401","volume":"203","author":"C Guiducci","year":"2006","unstructured":"Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee K-D, Coffman RL, Barrat FJ (2006) Properties regulating the nature of the plasmacytoid dendritic cell response to toll-like receptor 9 activation. J Exp Med 203:1999\u20132008","journal-title":"J Exp Med"},{"key":"10122_CR99","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1126\/science.1187029","volume":"329","author":"M Sasai","year":"2010","unstructured":"Sasai M, Linehan MM, Iwasaki A (2010) Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329:1530\u20131534","journal-title":"Science"},{"key":"10122_CR100","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature03547","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T (2005) Spatiotemporal regulation of MyD88\u2013IRF-7 signalling for robust type-I interferon induction. Nature 434:1035\u20131040","journal-title":"Nature"},{"key":"10122_CR101","doi-asserted-by":"publisher","first-page":"e1000240","DOI":"10.1371\/journal.ppat.1000240","volume":"4","author":"T Sheahan","year":"2008","unstructured":"Sheahan T, Morrison TE, Funkhouser W, Uematsu S, Akira S, Baric RS, Heise MT (2008) MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. PLoS Pathog 4:e1000240","journal-title":"PLoS Pathog"},{"key":"10122_CR102","doi-asserted-by":"publisher","first-page":"14830","DOI":"10.1038\/ncomms14830","volume":"8","author":"S Dallari","year":"2017","unstructured":"Dallari S, Macal M, Loureiro ME, Jo Y, Swanson L, Hesser C, Ghosh P, Zuniga EI (2017) Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses. Nat Commun 8:14830","journal-title":"Nat Commun"},{"key":"10122_CR103","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.4049\/jimmunol.166.4.2291","volume":"166","author":"N Kadowaki","year":"2001","unstructured":"Kadowaki N, Antonenko S, Liu Y-J (2001) Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c\u2212 type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol 166:2291\u20132295","journal-title":"J Immunol"},{"key":"10122_CR104","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/jmv.25987","volume":"92","author":"A Choudhury","year":"2020","unstructured":"Choudhury A, Mukherjee S (2020) In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol 92:2105\u20132113","journal-title":"J Med Virol"},{"key":"10122_CR105","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","volume":"20","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee S, Karmakar S, Babu SPS (2016) TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Braz J Infect Dis 20:193\u2013204","journal-title":"Braz J Infect Dis"},{"key":"10122_CR106","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1462-5822.2010.01540.x","volume":"13","author":"HH Mu","year":"2011","unstructured":"Mu HH, Hasebe A, Van Schelt A, Cole BC (2011) Novel interactions of a microbial superantigen with TLR2 and TLR4 differentially regulate IL\u201017 and Th17\u2010associated cytokines. Cell Microbiol 13:374\u2013387","journal-title":"Cell Microbiol"},{"key":"10122_CR107","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.brainresrev.2008.09.001","volume":"59","author":"E Okun","year":"2009","unstructured":"Okun E, Griffioen KJ, Lathia JD, Tang S-C, Mattson MP, Arumugam TV (2009) Toll-like receptors in neurodegeneration. Brain Res Rev 59:278\u2013292","journal-title":"Brain Res Rev"},{"key":"10122_CR108","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499\u2013511","journal-title":"Nat Rev Immunol"},{"key":"10122_CR109","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI Van Der Made","year":"2020","unstructured":"Van Der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, van Deuren RC, Steehouwer M, van Reijmersdal SV, Jaeger M (2020) Presence of genetic variants among young men with severe COVID-19. JAMA 324:663\u2013673","journal-title":"JAMA"},{"key":"10122_CR110","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1073\/pnas.1323279111","volume":"111","author":"J Zhao","year":"2014","unstructured":"Zhao J, Li K, Wohlford-Lenane C, Agnihothram SS, Fett C, Zhao J, Gale MJ Jr, Baric RS, Enjuanes L, Gallagher T (2014) Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111:4970\u20134975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10122_CR111","first-page":"49","volume":"27","author":"P Chansrichavala","year":"2009","unstructured":"Chansrichavala P, Chantharaksri U, Sritara P, Chaiyaroj SC (2009) Atorvastatin attenuates TLR4-mediated NF-[kappa] B activation in a MyD88-dependent pathway. Asian Pac J Allergy Immunol 27:49","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10122_CR112","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bbrc.2014.02.091","volume":"446","author":"X Yuan","year":"2014","unstructured":"Yuan X, Deng Y, Guo X, Shang J, Zhu D, Liu H (2014) Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4\/MYD88 pathway. Biochem Biophys Res Commun 446:292\u2013297","journal-title":"Biochem Biophys Res Commun"},{"key":"10122_CR113","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/jmv.26826","volume":"93","author":"S Khanmohammadi","year":"2021","unstructured":"Khanmohammadi S, Rezaei N (2021) Role of toll-like receptors in the pathogenesis of COVID-19. J Med Virol 93:2735\u20132739","journal-title":"J Med Virol"},{"key":"10122_CR114","doi-asserted-by":"crossref","unstructured":"Brandao SC, Ramos JD, Dompieri LT, Godoi ET, Figueiredo JL, Sarinho ES, Chelvanambi S, Aikawa M (2021) Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities? Cytokine Growth Factor Rev. 58:102\u2013110.","DOI":"10.1016\/j.cytogfr.2020.09.002"},{"key":"10122_CR115","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000545432","volume":"17","author":"AN Nguyen","year":"2025","unstructured":"Nguyen AN, Kouyate TS, Ryff K, Plotkin AL, Doss-Gollin S, Thomas S, McEnaney K, Ozonoff A, Diray-Arce J, Levy O (2025) Patients hospitalized with COVID-19 demonstrate distinct plasma cytokine and chemokine concentrations in vivo and TLR-mediated cytokine and chemokine production in whole blood in vitro. J Innate Immun 17:288\u2013301","journal-title":"J Innate Immun"},{"key":"10122_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00642","volume":"8","author":"M Shah","year":"2017","unstructured":"Shah M, Choi S (2017) Toll-like receptor-dependent negative effects of opioids: a battle between analgesia and hyperalgesia. Front Immunol 8:642. https:\/\/doi.org\/10.3389\/fimmu.2017.00642","journal-title":"Front Immunol"},{"key":"10122_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10437","volume":"22","author":"J Zhou","year":"2021","unstructured":"Zhou J, Ma R, Jin Y, Fang J, Du J, Shao X, Liang Y, Fang J (2021) Molecular mechanisms of opioid tolerance: from opioid receptors to inflammatory mediators. Exp Ther Med 22:1\u20138","journal-title":"Exp Ther Med"},{"key":"10122_CR118","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1753425918804635","volume":"26","author":"S Li","year":"2020","unstructured":"Li S, Chen X, Li J, Li X, Zhang T, Hao G, Sun J (2020) Extracellular ATP is a potent signaling molecule in the activation of the Japanese flounder (Paralichthys olivaceus) innate immune responses. Innate Immun 26:413\u2013423. https:\/\/doi.org\/10.1177\/1753425918804635","journal-title":"Innate Immun"},{"key":"10122_CR119","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bj.2017.06.010","volume":"40","author":"J Suurv\u00e4li","year":"2017","unstructured":"Suurv\u00e4li J, Boudinot P, Kanellopoulos J, R\u00fc\u00fctel Boudinot S (2017) P2X4: a fast and sensitive purinergic receptor. Biomed J 40:245\u2013256. https:\/\/doi.org\/10.1016\/j.bj.2017.06.010","journal-title":"Biomed J"},{"key":"10122_CR120","doi-asserted-by":"publisher","unstructured":"North RA (2016) P2X receptors. Philos Trans R Soc Lond B Biol Sci 371. https:\/\/doi.org\/10.1098\/rstb.2015.0427","DOI":"10.1098\/rstb.2015.0427"},{"key":"10122_CR121","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","volume":"67","author":"LEB Savio","year":"2017","unstructured":"Savio LEB, de Andra Mello P, Figliuolo VR, de Avelar Almeida TF, Santana PT, Oliveira SDS, Silva CLM, Feldbr\u00fcgge L, Csizmadia E, Minshall RD, Longhi MS, Wu Y, Robson SC, Coutinho-Silva R (2017) CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol 67:716\u2013726. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.021","journal-title":"J Hepatol"},{"key":"10122_CR122","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","volume":"12","author":"G Burnstock","year":"2016","unstructured":"Burnstock G (2016) P2X ion channel receptors and inflammation. Purinergic Signal 12:59\u201367. https:\/\/doi.org\/10.1007\/s11302-015-9493-0","journal-title":"Purinergic Signal"},{"key":"10122_CR123","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1523\/jneurosci.4930-11.2012","volume":"32","author":"JP de Rivero Vaccari","year":"2012","unstructured":"de Rivero Vaccari JP, Bastien D, Yurcisin G, Pineau I, Dietrich WD, De Koninck Y, Keane RW, Lacroix S (2012) P2X4 receptors influence inflammasome activation after spinal cord injury. J Neurosci 32:3058\u20133066. https:\/\/doi.org\/10.1523\/jneurosci.4930-11.2012","journal-title":"J Neurosci"},{"key":"10122_CR124","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nm1082","volume":"10","author":"X Wang","year":"2004","unstructured":"Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA, Nedergaard M (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821\u2013827. https:\/\/doi.org\/10.1038\/nm1082","journal-title":"Nat Med"},{"key":"10122_CR125","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00441-003-0758-5","volume":"313","author":"X Bo","year":"2003","unstructured":"Bo X, Kim M, Nori SL, Schoepfer R, Burnstock G, North RA (2003) Tissue distribution of P2X4 receptors studied with an ectodomain antibody. Cell Tissue Res 313:159\u2013165. https:\/\/doi.org\/10.1007\/s00441-003-0758-5","journal-title":"Cell Tissue Res"},{"key":"10122_CR126","doi-asserted-by":"publisher","first-page":"L58","DOI":"10.1152\/ajplung.00157.2018","volume":"316","author":"VE Winkelmann","year":"2019","unstructured":"Winkelmann VE, Thompson KE, Neuland K, Jaramillo AM, Fois G, Schmidt H, Wittekindt OH, Han W, Tuvim MJ, Dickey BF, Dietl P, Frick M (2019) Inflammation-induced upregulation of P2X(4) expression augments mucin secretion in airway epithelia. Am J Physiol Lung Cell Mol Physiol 316:L58-l70. https:\/\/doi.org\/10.1152\/ajplung.00157.2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10122_CR127","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47:15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020","journal-title":"Immunity"},{"key":"10122_CR128","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","volume":"26","author":"DE Ribeiro","year":"2021","unstructured":"Ribeiro DE, Oliveira-Giacomelli \u00c1, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H (2021) Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 26:1044\u20131059. https:\/\/doi.org\/10.1038\/s41380-020-00965-3","journal-title":"Mol Psychiatry"},{"key":"10122_CR129","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock G, Boeynaems JM (2014) Purinergic signalling and immune cells. Purinergic Signal 10:529\u2013564. https:\/\/doi.org\/10.1007\/s11302-014-9427-2","journal-title":"Purinergic Signal"},{"key":"10122_CR130","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1111\/bph.15138","volume":"177","author":"F Di Virgilio","year":"2020","unstructured":"Di Virgilio F, Tang Y, Sarti AC, Rossato M (2020) A rationale for targeting the P2X7 receptor in Coronavirus disease 19. Br J Pharmacol 177:4990\u20134994. https:\/\/doi.org\/10.1111\/bph.15138","journal-title":"Br J Pharmacol"},{"key":"10122_CR131","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1007\/s11010-021-04130-4","volume":"476","author":"MLM Franciosi","year":"2021","unstructured":"Franciosi MLM, Lima MDM, Schetinger MRC, Cardoso AM (2021) Possible role of purinergic signaling in COVID-19. Mol Cell Biochem 476:2891\u20132898. https:\/\/doi.org\/10.1007\/s11010-021-04130-4","journal-title":"Mol Cell Biochem"},{"key":"10122_CR132","doi-asserted-by":"crossref","unstructured":"Carvalho-Barbosa N, Cristina-Rodrigues F, Temerozo JR, Souza TM, Gouv\u00eaa AL, Canetti CA, Kurtenbach E, Bou-Habib DC, Benjamim CF, Takiya CM (2024) The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury. Purinergic Signal 21(3):465\u2013483","DOI":"10.1007\/s11302-024-10062-7"},{"key":"10122_CR133","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.pain.2010.02.042","volume":"150","author":"RJ Horvath","year":"2010","unstructured":"Horvath RJ, Romero-Sandoval AE, De Leo JA (2010) Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and \u03bc opioid receptor protein expression while enhancing perivascular microglial ED2. Pain 150:401\u2013413. https:\/\/doi.org\/10.1016\/j.pain.2010.02.042","journal-title":"Pain"},{"key":"10122_CR134","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri2938","volume":"11","author":"WG Junger","year":"2011","unstructured":"Junger WG (2011) Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 11:201\u2013212. https:\/\/doi.org\/10.1038\/nri2938","journal-title":"Nat Rev Immunol"},{"key":"10122_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.549179","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang X, Liu D, Qin W, Liu Y, Yuan X, Zhang X, Dai C, Zhang D (2020) P2RX1-involved glycolytic metabolism supports neutrophil activation in acute pancreatitis. Front Immunol 11:549179. https:\/\/doi.org\/10.3389\/fimmu.2020.549179","journal-title":"Front Immunol"},{"key":"10122_CR136","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11302-024-10062-7","volume":"21","author":"N Carvalho-Barbosa","year":"2025","unstructured":"Carvalho-Barbosa N, Cristina-Rodrigues F, Temerozo JR, Souza TM, Gouvea AL, Canetti CA, Kurtenbach E, Bou-Habib DC, Benjamim CF, Takiya CM (2025) The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury. Purinergic Signalling 21:465\u2013483","journal-title":"Purinergic Signalling"},{"key":"10122_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00399","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Chen D (2018) Purinergic regulation of neutrophil function. Front Immunol 9:399. https:\/\/doi.org\/10.3389\/fimmu.2018.00399","journal-title":"Front Immunol"},{"key":"10122_CR138","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11302-013-9357-4","volume":"9","author":"F Jacob","year":"2013","unstructured":"Jacob F, P\u00e9rez Novo C, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:285\u2013306. https:\/\/doi.org\/10.1007\/s11302-013-9357-4","journal-title":"Purinergic Signal"},{"key":"10122_CR139","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bbi.2020.07.026","volume":"89","author":"VS Alves","year":"2020","unstructured":"Alves VS, Leite-Aguiar R, Silva JPD, Coutinho-Silva R, Savio LEB (2020) Purinergic signaling in infectious diseases of the central nervous system. Brain Behav Immun 89:480\u2013490. https:\/\/doi.org\/10.1016\/j.bbi.2020.07.026","journal-title":"Brain Behav Immun"},{"key":"10122_CR140","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2018.04.006","volume":"205","author":"L Antonioli","year":"2019","unstructured":"Antonioli L, Fornai M, Blandizzi C, Pacher P, Hask\u00f3 G (2019) Adenosine signaling and the immune system: when a lot could be too much. Immunol Lett 205:9\u201315. https:\/\/doi.org\/10.1016\/j.imlet.2018.04.006","journal-title":"Immunol Lett"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-025-10122-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:04:05Z","timestamp":1777615445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-025-10122-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10122"],"URL":"https:\/\/doi.org\/10.1007\/s11302-025-10122-6","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}